Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  The Carlyle Group Inc.    CG

THE CARLYLE GROUP INC.

(CG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

AstraZeneca signs deal with Albany Molecular to produce COVID-19 vaccine candidate

share with twitter share with LinkedIn share with facebook
09/03/2020 | 10:54am EDT
FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the NYSE in New York

AstraZeneca Plc on Thursday signed a manufacturing deal with privately held Albany Molecular Research Inc to produce millions of doses of the British drugmaker's experimental coronavirus vaccine annually.

The contract drug manufacturer and research company said the agreeement will help bolster supply of the vaccine through sterile finishing services at its manufacturing plant in Albuquerque, New Mexico.

Albany Molecuar did not disclose the terms of the deal, while AstraZeneca did not immediately respond to a request for comment.

AstraZeneca has been scaling up production of the vaccine candidate, mainly through deals such as its expanded agreement with cell therapy firm Oxford Biomedica to mass-produce its COVID-19 vaccine candidate.

Albany Molecular in 2017 agreed to be taken private by buyout firms Carlyle Group and GTCR LLC for about $922 million in cash.

(Reporting by Manas Mishra in Bengaluru; Editing by Arun Koyyur)


Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC -0.26% 8056 Delayed Quote.6.18%
OXFORD BIOMEDICA PLC -1.09% 818 Delayed Quote.28.22%
THE CARLYLE GROUP INC. -1.83% 25.77 Delayed Quote.-18.17%
share with twitter share with LinkedIn share with facebook
All news about THE CARLYLE GROUP INC.
10/26CARLYLE LP : The Carlyle Group to acquire Calastone
PU
10/26CARLYLE LP : The Carlyle Group acquires prime French and German distribution log..
PU
10/26CARLYLE : to buy majority stake in funds network Calastone
RE
10/26The carlyle group says agreed to buy a majority stake in funds network calast..
RE
10/26Carlyle Nears EUR2 Billion Deal for Siemens's Flender Business -- Bloomberg
DJ
10/25Carlyle, Pacific Equity sweeten bid for Australia's Link, eye listing PEXA
RE
10/25LINK ADMINISTRATION : Australia's Link gets $2 bln raised takeover bid from Carl..
RE
10/25SIEMENS, CARLYLE NEAR $2.4 BILLION D : Bloomberg
RE
10/25BUSINESS ON BIDEN : Not So Bad, Given the Alternatives
DJ
10/22Australia's Link turns down Carlyle-Pacific Equity bid, says open to talks
RE
More news
Financials (USD)
Sales 2020 2 162 M - -
Net income 2020 633 M - -
Net cash 2020 1 591 M - -
P/E ratio 2020 14,6x
Yield 2020 3,81%
Capitalization 9 153 M 9 153 M -
EV / Sales 2020 3,50x
EV / Sales 2021 2,54x
Nbr of Employees 1 775
Free-Float 52,5%
Chart THE CARLYLE GROUP INC.
Duration : Period :
The Carlyle Group Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends THE CARLYLE GROUP INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Average target price 31,14 $
Last Close Price 26,25 $
Spread / Highest target 56,2%
Spread / Average Target 18,6%
Spread / Lowest Target 6,67%
EPS Revisions
Managers
NameTitle
Kewsong Lee Chief Executive Officer & Director
William E. Conway Executive Co-Chairman
David M. Rubenstein Executive Co-Chairman
Christopher Finn Chief Operating Officer
Curtis L. Buser Chief Financial Officer
Sector and Competitors
1st jan.Capitalization (M$)
THE CARLYLE GROUP INC.-18.17%9 153
THE BLACKSTONE GROUP INC.-5.54%36 553
LEGAL & GENERAL PLC-35.45%15 113
AMUNDI-15.31%14 058
FRANKLIN RESOURCES, INC.-12.09%11 311
ESR CAYMAN LIMITED33.52%9 275